FCM
IMMU

Frontier Capital Management’s Immunomedics Inc IMMU Stock Holding History

Frontier Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-606,968
Closed -$21.5M – 309
2020
Q2 		$21.5M Sell
606,968
-635,009
-51% -$18.6M 0.19% 160
2020
Q1 		$16.7M Buy
1,241,977
+42,460
+4% +$714K 0.19% 154
2019
Q4 		$25.4M Buy
1,199,517
+66,499
+6% +$1.17M 0.19% 155
2019
Q3 		$15M Buy
1,133,018
+445,401
+65% +$6.55M 0.12% 195
2019
Q2 		$9.54M Sell
687,617
-398,237
-37% -$5.99M 0.07% 228
2019
Q1 		$20.9M Buy
+1,085,854
New +$17.5M 0.15% 185

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Frontier Capital Management's IMMU Position: Q3 2020 in Review

Frontier Capital Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 606,968 shares — an estimated $21.5M sold.

Frontier Capital Management first reported a position in IMMU in Q1 2019 and held it in 6 quarters. The position peaked at $25.4M in Q4 2019. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Frontier Capital Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Frontier Capital Management sold 606,968 Immunomedics Inc shares in Q3 2020, an estimated $21.5M.
  • Frontier Capital Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 6 quarters.
  • Frontier Capital Management's Immunomedics Inc position peaked at $25.4M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Frontier Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.